Buscar
01/09/2025
Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum
Franquesa-Mullerat, M, Morcillo-Nieto, AO, Arriola-Infante, JE, Zsadanyi, SE, Vaqué-Alcázar, L, Rozalem-Aranha, M, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(9)DOI:10.1002/alz.70581. PMID:40968330. IF:11.100(Q1/1D).
01/09/2025
ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis
Olivé-Cirera, G, Falcioni, L, Fetta, A, Perez, EGF, Verdaguer, MG, Martinez, E, Sabaté, L, Saiz, A, Dalmau, J, Armangue, T. ADEM and other common radiological patterns shared in children with MOG-IgG and antibody-negative autoimmune encephalitis. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
01/09/2025
NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation
Velasco, JIF, Jorge, FR, Monreal, E, Gracia, J, Díaz, EF, Meca-Lallana, V, Villarrubia, N, de la Maza, SS, Cortegana, EMP, Quiroga-Varela, A, Ramio-Torrentá, L, Martínez-Yélamos, S, Vila, LB, Real, AML, Romero, AR, Canelo, LB, Nicolas, SD, Eguia, P, Espiño, M, Garcia, JLC, Hernandez, FJB, González, JLV, Meca-Lallana, JE, Martos, PG, Gines, MLM, García-Dominguez, JM, Moreno, I, Sainz, R, Mañe, A, Rodriguez, ABC, Pinedo, FC, Labiano, A, Ayuso, L, Abreu, R, Hernández, MA, Rodríguez, MR, Martín-Aguilar, L, González, AH, Rojas, FJV, Cabredo, LF, Sanchez-Seco, VG, Muñoz, JS, Polo, LF, Castañon, IG, Moreno, SMG, Masjuan, J, Costa-Frossard, L, Guimerans, LMV. NfL and GFAP treatment-response serum biomarkers are influenced by elapsed time from MS onset to ocrelizumab initiation. Multiple Sclerosis Journal. 2025; 31(3)DOI:. PMID:. IF:5.000(Q1/2D).
30/08/2025
Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona
Espasa, M, Pagán, B, Fernández-Pittol, M, Orcau, A, Tudó, G, Garcia, F, Martinez, JA, Soler, N, Horvath-Ruiz, L, San-Nicolás, L, Martinez, D, Casals-Pascual, C, Vila, J, Millet, JP, Caylà, JA, Gonzalez-Martin, J. Trends in Antituberculosis Drug Resistance and Associated Factors: A 31-Year Observational Study at a Tertiary Hospital in Barcelona. Antibiotics-Basel. 2025; 14(9)DOI:10.3390/antibiotics14090875. PMID:41009854. IF:4.600(Q1/2D).